Transcranial Magnetic Stimulation for Post-Traumatic Stress Disorder

Status Recruiting

Clinical Trial Summary

The purpose of this study is to determine if transcranial magnetic stimulation at 1 HZ to the right frontal cortex will decrease the symptoms of post-traumatic stress disorder (PTSD).

Clinical Trial Description

Post-traumatic stress disorder (PTSD) is a psychiatric disorder that is common in the general population. PTSD symptoms include re-experiencing the traumatic event, avoidance of reminders of the trauma, and increased arousal. The primary treatments of PTSD are psychotherapy and antidepressant medications. While both are effective, many patients continue to have significant symptoms. Repetitive Transcranial Magnetic Stimulation (rTMS) is a new research and treatment modality that uses a small powerful electromagnet to directly stimulate the brain. This stimulation may increase or decrease brain activity. The treatments have been shown to be effective in other disorders such as depression. Initial treatment of patients with PTSD using rTMS has been hopeful. This study is the first randomized controlled trial to examine the efficacy of rTMS for PTSD.

This study would be the first randomized placebo controlled trial to examine the efficacy of Transcranial Magnetic Stimulation (rTMS) for PTSD. The primary hypothesis is that there will be significant improvement in the patients' PTSD symptoms from pre-treatment to post-treatment with rTMS. A secondary hypothesis is that the patients’ co-morbid depressive symptoms will improve from pre-treatment to post-treatment. Forty subjects with PTSD will be recruited from the White River Junction VAMC. Patients will be randomly assigned to receive either active rTMS or sham rTMS. Patients, staff performing the treatments, and staff completing the assessments will all be blinded to active or sham treatment. ;

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00134446
Study type	Interventional
Source	White River Junction VAMC
Contact	Bradley V Watts, MD
Phone	802-295-9363
Email	bradley.v.watts@dartmouth.edu
Status	Recruiting
Phase	Phase 4
Start date	March 2004

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04032301` - Repeated Ketamine Infusions for Comorbid PTSD and MDD in Veterans	Phase 1
Withdrawn	`NCT00641173` - Early Intervention for Post Traumatic Stress Disorder (PTSD)	N/A
Completed	`NCT00564317` - KIDNET vs Meditation/Relaxation - a Dissemination Randomized Controlled Trial for the Treatment of Traumatized Children After War in Sri Lanka	Phase 3
Recruiting	`NCT02512445` - Trauma Informed Guilt Reduction Therapy	N/A
Completed	`NCT00100490` - Immune and Endocrine Function in Post-Traumatic Stress Disorder	N/A
Terminated	`NCT03605342` - Optimal Treatment of Veterans With PTSD and Comorbid OUD	Phase 2
Terminated	`NCT02824445` - To Evaluate the Efficacy of EEG-guided Magnetic Resonant Therapy in War Veterans With Posttraumatic Stress Disorder	N/A
Recruiting	`NCT03152175` - Posttraumatic Stress Disorders in Police, Correctional Service Officers, and 911 Operators	Phase 2
Completed	`NCT02080351` - A Simple Cognitive Task to Reduce the Build-Up of Flashbacks After a Road Traffic Accident	N/A
Completed	`NCT00974402` - Psychotherapy Treatment of Deployment-Related PTSD in Primary Care Settings	N/A
Not yet recruiting	`NCT02384369` - Trial of Oral SNC-102 in Subjects With Combat-Related Posttraumatic Stress Disorder	Phase 2
Completed	`NCT00120250` - Eszopiclone for Sleep Disturbance and Nightmares in Post-Traumatic Stress Disorder	Phase 4
Completed	`NCT00039715` - Effects of Hydrocortisone in Patients With Post-Traumatic Stress Disorder	N/A
Recruiting	`NCT04368689` - The Feasibility and Examination of the Effects of Floatation-based REST on a Community Sample With PTSD	N/A
Completed	`NCT01060553` - Pilot of Acupuncture to Improve Quality of Life in Veterans With TBI and PTSD	N/A
Completed	`NCT00227357` - The CORE Buprenorphine Project - An HIV Primary Care Program Demonstration	N/A
Completed	`NCT02927288` - Identifying Biomarkers That Distinguish PTSD and mTBI Using Advanced Magnetic Resonance Spectroscopy	N/A
Completed	`NCT01278316` - Rural Veterans With Post-traumatic Stress Disorder (PTSD) And Comorbid Mild Traumatic Brain Injury (TBI): A Feasibility Study	N/A
Completed	`NCT00778960` - Mechanistic Pathways of Mindfulness Meditation in Post-traumatic Stress Disorder.	N/A
Completed	`NCT00288314` - fMRI in Posttraumatic Stress Disorder (PTSD) During Working Memory Updating	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.